Published in Mov Disord on June 01, 2006
A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron (2011) 18.73
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord (2008) 9.52
Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron (2010) 7.87
Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Mov Disord (2007) 3.86
Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial. JAMA (2003) 3.49
White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study. Neurobiol Aging (2005) 2.79
A multicenter retrieval study of the taper interfaces of modular hip prostheses. Clin Orthop Relat Res (2002) 2.78
Transient increase in breast cancer risk after giving birth: postpartum period with the highest risk (Sweden). Cancer Causes Control (2002) 2.39
Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. J Neurochem (2005) 2.36
Association between late-life social activity and motor decline in older adults. Arch Intern Med (2009) 2.26
Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions. Mov Disord (2008) 1.78
Rating scales for dystonia: a multicenter assessment. Mov Disord (2003) 1.77
Self-reported experiences of everyday discrimination are associated with elevated C-reactive protein levels in older African-American adults. Brain Behav Immun (2009) 1.75
Diffusion tensor imaging of Parkinson's disease, atypical parkinsonism, and essential tremor. Mov Disord (2013) 1.68
Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease. J Neurochem (2006) 1.67
Hippocampal disconnection contributes to memory dysfunction in individuals at risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2006) 1.63
Birthweight differences between USA and China and their relevance to breast cancer aetiology. Int J Epidemiol (2003) 1.59
Physical frailty in older persons is associated with Alzheimer disease pathology. Neurology (2008) 1.59
Reference data for commonly used sensory and motor nerve conduction studies. Muscle Nerve (2009) 1.57
Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment. J Neuropathol Exp Neurol (2006) 1.56
Progressive worsening of spatial and chromatic processing deficits in Parkinson disease. Arch Neurol (2002) 1.55
Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease. Exp Neurol (2002) 1.54
Microarray analysis of hippocampal CA1 neurons implicates early endosomal dysfunction during Alzheimer's disease progression. Biol Psychiatry (2010) 1.49
Acute stroke care in Illinois: a statewide assessment of diagnostic and treatment capabilities. Stroke (2002) 1.48
Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease. J Neuropathol Exp Neurol (2004) 1.48
Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial. J Child Adolesc Psychopharmacol (2006) 1.47
Neuronal LR11/sorLA expression is reduced in mild cognitive impairment. Ann Neurol (2007) 1.45
Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease. Ann Neurol (2004) 1.43
The localizing yield of sphenoidal and anterior temporal electrodes in ictal recordings: a comparison study. Epilepsia (2002) 1.41
Dementia from Alzheimer disease and mixed pathologies in the oldest old. JAMA (2012) 1.40
Developing reference data for nerve conduction studies: an application of quantile regression. Muscle Nerve (2009) 1.39
Association of anxiety and depression with microtubule-associated protein 2- and synaptopodin-immunolabeled dendrite and spine densities in hippocampal CA3 of older humans. Arch Gen Psychiatry (2010) 1.27
Tremor and ataxia in fragile X premutation carriers: blinded videotape study. Ann Neurol (2003) 1.22
Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J Comp Neurol (2002) 1.19
Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's disease. Mov Disord (2002) 1.15
Progression of gait, speech and swallowing deficits in progressive supranuclear palsy. Neurology (2003) 1.12
A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events. Epilepsy Behav (2003) 1.09
Motor neuron involvement in multisystem proteinopathy: implications for ALS. Neurology (2013) 1.08
Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer's neuropathology. J Alzheimers Dis (2003) 1.07
Progression of tau pathology in cholinergic Basal forebrain neurons in mild cognitive impairment and Alzheimer's disease. Am J Pathol (2011) 1.07
Short-term and practice effects of metronome pacing in Parkinson's disease patients with gait freezing while in the 'on' state: randomized single blind evaluation. Parkinsonism Relat Disord (2004) 1.05
A random change point model for cognitive decline in Alzheimer's disease and mild cognitive impairment. Neuroepidemiology (2012) 1.05
Regional selectivity of rab5 and rab7 protein upregulation in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis (2010) 1.04
The Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in Huntington's disease. Mov Disord (2010) 1.04
Association of total daily physical activity with disability in community-dwelling older persons: a prospective cohort study. BMC Geriatr (2012) 1.04
Increased matrix metalloproteinase 9 activity in mild cognitive impairment. J Neuropathol Exp Neurol (2009) 1.01
Determinants of quality of life in children with Gilles de la Tourette syndrome. Mov Disord (2009) 1.01
Presymptomatic studies in ALS: rationale, challenges, and approach. Neurology (2012) 1.00
Galanin fiber hypertrophy within the cholinergic nucleus basalis during the progression of Alzheimer's disease. Dement Geriatr Cogn Disord (2006) 0.97
Assuring interrater reliability for the UPDRS motor section: utility of the UPDRS teaching tape. Mov Disord (2004) 0.97
Hippocampal proNGF signaling pathways and β-amyloid levels in mild cognitive impairment and Alzheimer disease. J Neuropathol Exp Neurol (2012) 0.97
Which dyskinesia scale best detects treatment response? Mov Disord (2013) 0.97
Teaching program for the Unified Dyskinesia Rating Scale. Mov Disord (2009) 0.96
Characterization of potential outcome measures for future clinical trials in fragile X syndrome. J Autism Dev Disord (2008) 0.95
GFAP knockout mice have increased levels of GDNF that protect striatal neurons from metabolic and excitotoxic insults. J Comp Neurol (2003) 0.95
Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system. Arch Neurol (2004) 0.95
Superior frontal cortex cholinergic axon density in mild cognitive impairment and early Alzheimer disease. Arch Neurol (2007) 0.95
Hippocampal drebrin loss in mild cognitive impairment. Neurodegener Dis (2012) 0.94
Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF. Exp Neurol (2003) 0.94
Teaching program for the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale: (MDS-UPDRS). Mov Disord (2010) 0.93
Mycophenolate mofetil for myasthenia gravis: a double-blind, placebo-controlled pilot study. Ann N Y Acad Sci (2003) 0.93
Hallucinations and sleep disorders in PD: six-year prospective longitudinal study. Neurology (2005) 0.93
The malignant course of "benign hallucinations" in Parkinson disease. Arch Neurol (2006) 0.92
Daytime somnolence and nocturnal sleep disturbances in Huntington disease. Parkinsonism Relat Disord (2008) 0.92
Treatment of ocular symptoms in myasthenia gravis. Neurology (2008) 0.92
Evaluating Parkinson's disease patients at home: utility of self-videotaping for objective motor, dyskinesia, and ON-OFF assessments. Mov Disord (2008) 0.92
Reduction of choline acetyltransferase activity in primary visual cortex in mild to moderate Alzheimer's disease. Arch Neurol (2005) 0.91
Preservation of cortical sortilin protein levels in MCI and Alzheimer's disease. Neurosci Lett (2010) 0.90
Is there a link between cancer and Alzheimer disease? Neurology (2009) 0.90
Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patients. Mov Disord (2006) 0.87
Vibratory thresholds and mobility in older persons. Muscle Nerve (2009) 0.87
Cortical alpha7 nicotinic acetylcholine receptor and beta-amyloid levels in early Alzheimer disease. Arch Neurol (2009) 0.86
Upregulation of select rab GTPases in cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease. J Chem Neuroanat (2011) 0.86
Wheeled and standard walkers in Parkinson's disease patients with gait freezing. Parkinsonism Relat Disord (2003) 0.85
Variability of EMG patterns: a potential neurophysiological marker of Parkinson's disease? Clin Neurophysiol (2008) 0.85
Impact of presymptomatic genetic testing for familial amyotrophic lateral sclerosis. Genet Med (2011) 0.85
Rating scale for psychogenic movement disorders: scale development and clinimetric testing. Mov Disord (2005) 0.85
Complementary and alternative medicine use in Gilles de la Tourette syndrome. Mov Disord (2009) 0.84
Aberrant septin 11 is associated with sporadic frontotemporal lobar degeneration. Mol Neurodegener (2011) 0.84
Relation of driving status to incident life space constriction in community-dwelling older persons: a prospective cohort study. J Gerontol A Biol Sci Med Sci (2012) 0.84
Effects of estrogen replacement therapy on cholinergic basal forebrain neurons and cortical cholinergic innervation in young and aged ovariectomized rhesus monkeys. J Comp Neurol (2004) 0.83
The CETP I405V polymorphism is associated with an increased risk of Alzheimer's disease. Aging Cell (2011) 0.83
An exploration of subgroups of mild cognitive impairment based on cognitive, neuropsychiatric and functional features: analysis of data from the National Alzheimer's Coordinating Center. Am J Geriatr Psychiatry (2011) 0.83
Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease. Arch Neurol (2003) 0.83
Inability of plasma and urine F2A-isoprostane levels to differentiate mild cognitive impairment from Alzheimer's disease. Neurodegener Dis (2010) 0.82
Gray-matter macrostructure in cognitively healthy older persons: associations with age and cognition. Brain Struct Funct (2013) 0.82